{
    "Trade/Device Name(s)": [
        "MSC Lipid Control"
    ],
    "Submitter Information": "Maine Standards Company",
    "510(k) Number": "k103271",
    "Predicate Device Reference 510(k) Number(s)": [
        "K012513",
        "K082067"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "December 21, 2010",
    "Summary Letter Received Date": "December 29, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "High-density Lipoprotein Cholesterol (HDL-C)",
        "Low-density Lipoprotein Cholesterol (LDL-C)",
        "Total Cholesterol (CHOL)",
        "Triglycerides (TRIG)",
        "Apolipoprotein AI (Apo AI)",
        "Apolipoprotein B (Apo B)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for MSC Lipid Control assayed and unassayed quality control material for lipid analytes in human serum.",
    "Indications for Use Summary": "Intended for use as an assayed quality control material to monitor the ongoing precision of clinical laboratory systems for HDL-C, LDL-C, Total Cholesterol, Triglycerides, Apo AI, and Apo B.",
    "fda_folder": "Clinical Chemistry"
}